Form 4: Eli Lilly Director Defers Compensation into Stock Units

Eli Lilly & Co. Director Mary Lynne Hedley acquired 13.011 shares of common stock through a deferred compensation plan, increasing her beneficial ownership.

Summary

• Director Mary Lynne Hedley acquired 13.011 shares of Eli Lilly & Co. common stock.
• The acquisition occurred on July 21, 2025.
• The shares were acquired at a price of $762.18 per share.
• These shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan.
• The stock units will be settled in shares of common stock following her separation from service.
• Following this transaction, Mary Lynne Hedley beneficially owns 1,972.574 shares directly and 98 shares indirectly through a trust.

Sentiment

Score: 7

Explanation: A director increasing their equity stake, even through a deferral plan, generally signals confidence in the company's long-term prospects and aligns their interests with shareholders.

Positives

• Director Mary Lynne Hedley increased her beneficial ownership in Eli Lilly & Co. by acquiring 13.011 shares.
• The acquisition through a deferral plan aligns the director's interests with long-term shareholder value.

Future Outlook

The acquired stock units will be settled in shares of common stock following the reporting person's separation from service.

Management Comments

• At the election of the reporting person, the shares acquired have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This Form 4 reports a routine insider transaction, indicating a director's election to receive equity over cash compensation, which is a common practice in corporate governance to align director interests with long-term shareholder value.

Comparison to Industry Standards

• This is a standard practice for director compensation plans in large public companies, where directors can elect to defer cash compensation into equity to align their interests with shareholders.
• Companies like Pfizer, Merck, and Johnson & Johnson often implement similar director deferral plans as part of their corporate governance and compensation strategies.

Corporate Governance

Related Party Transactions

• Acquisition of common stock by a director through the Lilly Directors' Deferral Plan in lieu of cash compensation.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased equity ownership.
• Management: Reinforces a culture of equity-based compensation for directors.

Next Steps

• Shares will be settled in common stock following the reporting person's separation from service.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction where a director acquired shares through a deferred compensation plan. While it indicates alignment of interests, it does not present new information that would fundamentally alter the investment thesis for Eli Lilly & Co. It's a standard compensation mechanism and not a signal for a significant change in company prospects or valuation.

Keywords

Eli Lilly, LLY, Form 4, insider transaction, director compensation, stock units, deferred compensation